Cover Image
市場調查報告書

全球創傷護理用生技藥品市場:產業趨勢與預測

Wound Care Biologics Market - Global Industry Insights, and Forecast to 2025

出版商 Coherent Market Insights 商品編碼 629674
出版日期 內容資訊 英文 183 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球創傷護理用生技藥品市場:產業趨勢與預測 Wound Care Biologics Market - Global Industry Insights, and Forecast to 2025
出版日期: 2018年04月06日 內容資訊: 英文 183 Pages
簡介

本報告提供全球創傷護理用生技藥品市場相關調查,彙整市場概要和各產品類型,各用途,各終端用戶,各地區趨勢,及加入此市場的主要企業的簡介等資料。

第1章 調查目的與假設

第2章 市場概要

第3章 市場趨勢,法律規章,趨勢分析

  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 市場機會
    • 產業趨勢
  • 技術進步
  • 法律規章方案
  • 給付方案
  • 主要的焦點
  • PEST分析
  • 流行病學
  • 影響分析

第4章 各產品類型

  • 簡介
  • 人造皮膚
  • 酵素製劑
  • 生長因子

第5章 各用途

  • 簡介
  • 慢性創傷
  • 急性創傷

第6章 各終端用戶

  • 簡介
  • 醫院
  • 診所
  • 門診外科中心
  • 居家護理設施

第7章 各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭環境

  • 熱圖分析
  • 市場佔有率分析
  • 企業簡介

第9章 章節

目錄

Wound care biologic products facilitates in innate repair mechanisms, and involves the use of active biological agents such as animal and plant-derived active biomolecules, which exhibit antioxidant, antimicrobial, or anti-inflammatory properties. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Biologic skin substitute products include tissue-engineered products, which are designed to either temporarily or permanently replace the altered skin. Skin substitutes are commonly used products for wound management and have application for treating various ailments such as pressure ulcers, diabetic neuropathic ulcers, and vascular insufficiency ulcers.

Market Dynamics

Increasing incidences of chronic ulcers, owing to rising prevalence of diabetes, increasing surgical procedures, and rise in trauma cases are major driving factors for growth of wound care biologics market. According to the survey by World Health Organization, 2014, injuries resulting from traffic collisions, drowning, poisoning, falls or burns account for 9% of the global mortality. Also, according to a study by BMJ Journal Injury Prevention, 2013, an estimated 973 million people sustained injuries that warranted some type of healthcare and 4.8 million people died from injuries. The Journal also stated that major injury causes included road injury (29.1%), self-harm (17.6%), falls (11.6%), and interpersonal violence (8.5%). Manufacturers are also focused on extensive research and development to develop new products and expand their product portfolio. For instance, in 2016, Integra LifeSciences Holdings Corporation received FDA approval for Integra Dermal Regeneration Template (IDRT) for the treatment of diabetic foot ulcers that is marketed under the name of Integra Omnigraft Dermal Regeneration Matrix. Moreover, public awareness for biologics has positively contributed to the market growth, as people are opting for enhanced medical care for preventing wounds to minimize the morbidity associated with the formation of chronic wounds. However, higher cost of the biologics and stringent regulatory approvals for launch of innovative tissue engineered products are hindering growth of the wound care biologics market.

Key features of the study:

This report provides in-depth analysis of wound care biologics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global wound care biologics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include Smith & Nephew Plc., Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amino Technology LLC, and Osiris Therapeutics, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics

The global wound care biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the wound care biologics market

Detailed Segmentation:

  • Global Wound Care Biologics Market, By Product Type:
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors
  • Global Wound Care Biologics Market, By Application:
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns
  • Global Wound Care Biologics Market, By End User:
  • Hospitals
  • In-patient Settings
  • Out-patient Settings
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Global Wound Care Biologics Market, By Geography:
  • North America
  • By Product Type:
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors
  • By Application:
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns
  • By End User:
  • Hospitals
  • In-patient Settings
  • Out-patient Settings
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Product Type:
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors
  • By Application:
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns
  • By End User:
  • Hospitals
  • In-patient Settings
  • Out-patient Settings
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product Type:
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors
  • By Application:
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns
  • By End User:
  • Hospitals
  • In-patient Settings
  • Out-patient Settings
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors
  • By Application:
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns
  • By End User:
  • Hospitals
  • In-patient Settings
  • Out-patient Settings
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type:
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors
  • By Application:
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns
  • By End User:
  • Hospitals
  • In-patient Settings
  • Out-patient Settings
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth factors
  • By Application:
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Acute Wounds
  • Surgical Wounds
  • Burns
  • By End User:
  • Hospitals
  • In-patient Settings
  • Out-patient Settings
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Smith & Nephew Plc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
  • Organogenesis, Inc.
  • Integra Lifesciences Holdings Corporation
  • Skye Biologics
  • Alphatec Holdings, Inc.
  • Solsys Medical LLC
  • Amino Technology LLC
  • Osiris Therapeutics, Inc.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Industry Trends
  • Technological Advancements
  • Regulatory Scenario
  • Reimbursement Scenario
  • Key Highlights
  • PEST Analysis
  • Epidemiology
  • Impact Analysis

4. Global Wound Care Biologics Market, By Product Type, 2015-2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2015 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
  • Biologic Skin Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Enzyme Based Formulations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Growth Factors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)

5. Global Wound Care Biologics Market, By Application, 2015-2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2015 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
  • Chronic Wounds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
    • Segment Trends
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Pressure Ulcers
  • Acute Wounds
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
    • Segment Trends
    • Surgical Wounds
    • Burns

6. Global Wound Care Biologics Market, By End User, 2015-2025, (US$ Million)

  • Introduction
    • Market Share Analysis, 2015 and 2025 (%)
    • Y-o-Y Growth Analysis, 2016-2025
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
    • Segment Trends
    • In-patient Settings
    • Out-patient Settings
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)

7. Global Wound Care Biologics Market, By Region, 2015-2025, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2015 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2016-2025
  • North America
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Application, 2015-2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Application, 2015-2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Application, 2015-2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Application, 2015-2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Application, 2015-2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Application, 2015-2025, (US$ Million)
    • Market Size and Forecast, By End User, 2015-2025, (US$ Million)
    • Market Size and Forecast, By Country, 2015-2025, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Smith & Nephew Plc.*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Organogenesis, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Integra Lifesciences Holdings Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Skye Biologics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Alphatec Holdings, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Solsys Medical LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Amino Technology LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
    • Osiris Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact

Browse 38 market data tables and 26 figures on "Wound Care Biologics Market - Global forecast to 2025".

Back to Top